“Real-World Clinician- and Patient-Reported Outcomes and Treatment Persistence Following Bimekizumab Initiation in Patients with Psoriasis: 6-Month Results from the PPD CorEvitas Psoriasis Registry” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s632. doi:10.25251/6744kd41.